import Post from '../../../components/Post.astro';

<Post 
  author={{"name":"Rick Byers","handle":"RickByersLab","avatar":"/postmedia/RickByersLab.jpg"}}
  date="2021-10-26T03:20:19.000Z"
  media={[]}
  faves={72}
  reposts={15}
  url="/posts/2021/20211025t232019"
  sourceUrl="https://x.com/RickByersLab/status/1452837469641224193"
>
Finally the US is fixing its regulatory approach to rapid tests, with the NIH helping to "work towards the right benchmarks for performance".  We know people are contagious for less than half the time they're infected, something current FDA and HC rules don't seem to account for. <a href="https://x.com/michaelmina_lab/status/1452818581062836227" target="_blank" rel="noopener noreferrer">https://x.com/michaelmina_lab/status/1452818581062836227</a>
</Post>

<Post 
  author={{"name":"Rick Byers","handle":"RickByersLab","avatar":"/postmedia/RickByersLab.jpg"}}
  date="2021-10-26T03:22:33.000Z"
  media={[]}
  faves={3}
  reposts={1}
  url="/posts/2021/20211025t232019"
  sourceUrl="https://x.com/RickByersLab/status/1452838030398590978"
>
This seems to be why good tests like Abbott Panbio are available in Canada for asymptomatic use only "off-label" in a few provinces.
</Post>

